Cheshire, CT, United States of America

Aaron Zomback

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Aaron Zomback

Introduction

Aaron Zomback is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of respiratory syncytial virus (RSV) vaccines. With a total of 2 patents, Zomback's work is paving the way for advancements in therapeutic methods and antibody production.

Latest Patents

Zomback's latest patents focus on conformationally stabilized RSV pre-fusion F proteins. The present invention provides mutant RSV F molecules that can be stabilized in a pre-fusion conformation through the introduction of one or more DT cross-links. This innovation also includes methods for creating such mutant RSV F molecules, compositions that comprise these molecules, and various methods of use, including vaccination and therapeutic applications.

Career Highlights

Throughout his career, Aaron Zomback has demonstrated a commitment to advancing medical science through his innovative inventions. His work has the potential to significantly impact the way RSV is treated and prevented, showcasing his dedication to improving public health.

Collaborations

Zomback has collaborated with talented individuals such as Mark Yondola and Sonal Gidwani. These partnerships have likely contributed to the success of his innovative projects and patents.

Conclusion

Aaron Zomback's contributions to the field of biotechnology, particularly through his patents on RSV pre-fusion F proteins, highlight his role as a significant inventor. His work continues to inspire advancements in medical science and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…